Formulation and Characterization of Curcumin-Loaded Aquasomes for Topical Fungal Treatment
DOI:
https://doi.org/10.22270/ajprd.v13i1.1496Abstract
The topical treatment of fungal infections remains a significant challenge due to the limited bioavailability of many therapeutic agents when applied on the skin. Curcumin, a naturally occurring polyphenolic compound derived from Curcuma longa, has demonstrated notable antifungal, anti-inflammatory, and antioxidant properties, making it an ideal candidate for the treatment of skin infections. However, its hydrophobic nature and poor solubility in water limit its therapeutic efficacy. To address these limitations, this study aimed to develop and evaluate curcumin-loaded aquasomes as a novel drug delivery system for topical fungal treatment. Aquasomes are a type of nanoparticulate carrier composed of a stabilizer, such as gelatin, and a surfactant, such as Tween 80, which are cross-linked with glutaraldehyde to form a stable, nanostructured system that encapsulates the drug. The curcumin-loaded aquasomes were prepared using the solvent evaporation method, followed by characterization of vesicle size, surface charge, entrapment efficiency, in vitro drug release, and release kinetics. The results showed that the optimized formulation (F3) had a vesicle size of 125.65 nm, a surface charge of 36.85 mV, and an entrapment efficiency of 82.23%. The in vitro release studies revealed a sustained release of curcumin over 12 hours, with 98.12% of the drug being released. The release data followed Korsmeyer-Peppas kinetics, indicating a diffusion-controlled release mechanism. The TEM analysis confirmed the formation of spherical nanoparticles with a uniform size distribution. The developed curcumin-loaded aquasomes exhibited promising characteristics, including enhanced solubility, controlled release, and high stability, making them a potential candidate for topical fungal treatment. These findings suggest that aquasome-based formulations can significantly improve the therapeutic efficacy of curcumin, offering a novel approach for the treatment of fungal skin infections.
Downloads
References
Almeida, A. J., & Silva, A. C. (2014). Nanoparticle-based systems for the delivery of bioactive compounds: A promising strategy to treat fungal infections. International Journal of Pharmaceutics, 471(1–2), 34-46.
Chakraborty, M., & Lahiri, D. (2016). Aquasomes as potential nanocarriers in drug delivery applications. International Journal of Nanomedicine, 11, 101-112.
Dandawate, P. R., & Soni, S. S. (2016). Curcumin and its formulations as potential antifungal agents: Current status and future prospects. Bioorganic & Medicinal Chemistry Letters, 26(15), 3426-3433.
Saha, M., & Bose, S. (2019). Development and evaluation of nanocarrier-based drug delivery systems for topical applications. Journal of Drug Delivery Science and Technology, 53, 101-113.
Yallapu, M. M., & Gupta, B. K. (2017). Curcumin and curcumin-loaded nanocarriers for the treatment of fungal infections. European Journal of Pharmaceutical Sciences, 108, 1-10.
Oviedo R.I., Lopez S.A.D., Gasga R.J., Barreda C.T.Q. Elaboration and structural analysis of aquasomes loaded with indomethecin. Eur J Pharm Sci. 2007; 32:223-230.
Vyas S.P., Goyal A.K., Khatri K., Mishra N., Mehta A., Vaidya, B., et al.Aquasomes a nanoparticulate approach for the delivery of antigen. Drug Dev Ind Pharm. 2008; 34:1297-1305.
Khopade A.J., Khopade S., Jain N.K. Development of haemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of poly (amidoamine) dendrimer. Drug Dev Ind Pharm. 2002; 241:145-54.
Patel, S., et al.,Aquasomes: a novel approach in drug carrier system. 2018. Banerjee S, Sen KK. Aquasomes: A novel nanoparticulate drug carrier. J Drug Deliv Sci Technol 2018; 43:446-452.
Jain SS, Jagtap PS, Dand NM, Jadhav KR, Kadam VJ. Aquasomes: a novel drug carrier. J Appl Pharm 2012; 2(1):184-192.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Mrigendra Kumar Patel, Sunil Shah, B. K. Dubey, Deepak Kumar Basedia, Prabhat Kumar Jain

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).